ID
18029
Description
Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00141700
Link
https://clinicaltrials.gov/show/NCT00141700
Keywords
Versions (1)
- 10/15/16 10/15/16 -
Uploaded on
October 15, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Lymphoma, Non-Hodgkin's NCT00141700
Eligibility Lymphoma, Non-Hodgkin's NCT00141700
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Similar models
Eligibility Lymphoma, Non-Hodgkin's NCT00141700
- StudyEvent: Eligibility
C3888518 (UMLS CUI [1,2])
C1512858 (UMLS CUI [2])
C1512431 (UMLS CUI [3])
C1398349 (UMLS CUI [2])
C0079757 (UMLS CUI [3])
C0079744 (UMLS CUI [4])
C1321546 (UMLS CUI [5])
C0334634 (UMLS CUI [6])
C0079741 (UMLS CUI [2])
C0079740 (UMLS CUI [3])
C1512894 (UMLS CUI [4])
C0334634 (UMLS CUI [5])
C0677874 (UMLS CUI [1,2])
C1708063 (UMLS CUI [2,1])
C1521726 (UMLS CUI [2,2])
C1522326 (UMLS CUI [1,2])
C0154728 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3])
C1517560 (UMLS CUI [4])
C0007806 (UMLS CUI [5,1])
C1513916 (UMLS CUI [5,2])
C2986497 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C3887511 (UMLS CUI [2,2])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])